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Appraisal
Appraisal of Clinical Practice Guideline: 2018 update of the EULAR
recommendations for the management of hand osteoarthritis
Dateoflatestupdate:August2018.Dateofnextupdate:Notspecified.Patientgroup:People
with hand osteoarthritis (OA). Intended audience: Not specified. Additional versions: Eu-
ropean League Against Rheumatism (EULAR) hand OA guideline published in 2007. Expert
workinggroup: Theexpertworkinggroup comprisedone convenor, onemethodologist, one
fellow, and a further task force of 10 rheumatologists, one plastic surgeon, three healthcare
professionals in the field of physiotherapy and occupational therapy, two patient research
partners, and two Emerging EUlar NETwork (EMEUNET) members. Funded by: This clinical
practice guideline was funded by EULAR. Consultation with: No consultations beyond the
expert working group were specified. Approved by: The final manuscript was reviewed,
revised and approved by all task force members, followed by a final review by the EULAR
Executive Committee. Location: https://doi.org/10.1136/annrheumdis-2018-213826.
Description and key recommendations: The 2018 EULAR guidelines were developed to
update an existing guideline published in 2007 for the evidence-basedmanagement of hand
OA. The level of evidence and grade of evidencewere computed regarding each recommen-
dation, according to the Oxford Centre for Evidence-BasedMedicine standards. According to
the results of this guideline, based on expert opinion and research evidence, five overarching
principleswere agreedupon. These overarching principleswere related to goals of treatment,
providing enough information to patients, individualising the treatment according to each
patient, shared decision-making, and having a multidisciplinary approach to hand OA
treatment, incorporating non-pharmacological, pharmacological and surgical treatment op-
tions. Inaddition tothesefiveoverarchingprinciples,10recommendationswerealsomadeby
the task force, as summarised inTable1 of theguideline. Thefirst three recommendations are
relatedtothenon-pharmacologicaltreatmentoptionsforhandOAmanagement.Thenextfive
recommendations (recommendations4 to8) illustrate the roleofpharmacologicaloptions for
treating handOA, including topical treatments, oral analgesics, chondroitin sulfate, and intra-
articular glucocorticoids (not recommended). Recommendations 9 and 10 focus on surgical
considerationsandfollow-upof thehandOApatients, respectively.Aresearchagendaforhand
OA is created and presented in Table 2 of the guideline. This agenda covers different themes,
from pathophysiology to different treatment options for hand OA.
Provenance: Invited. Not peer reviewed.
Armaghan Dabbagh and Joy C MacDermid
School of Physical Therapy, Western University, London, Canada
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Appraisal of Clinical Practice Guideline: Physiotherapy for cystic fibrosis in
Australia and New Zealand
Date of latest update: 2019. Date of next update: Not stated. Patient group: People with
cystic fibrosis in Australia and New Zealand. Intended audience: Physiotherapists. Addi-
tionalversions: Thisguidelinebuildsonapreviousconsensus statementpublished in20081
andanevaluationof its uptakeand impactpublished in2013.2 Theguideline canbeaccessed
as apublished journal article,3 aswell asanExecutiveSummaryandComprehensiveVersion
fromtheThoracicSocietyofAustraliaandNewZealandwebsite.4Expertworkinggroup:All
physiotherapists providing regular care for people with cystic firobsis in paediatric or adult
settings in Australia or New Zealand were invited to participate. The final expert working
group included: one chairperson, one editor, 12 group leaders and another 25 members,
who were all physiotherapists working with indivudals with cystic fibrosis. Funded by:
The guidelines were partially funded by a grant from Cystic Fibrosis Australia. The prior
2008 consensus statement was partially funded by Roche Pharmaceuticals and Solvay
Pharmaceuticals. Consultation with: The draft document was reviewed by stakeholders,
including: physicians caring for people with cystic fibrosis, people with cystic fibrosis,
allied health professionals and expert physiotherapists who were not part of the writing
group. Approved by: The original 2008 consensus statement was endorsed by the
Thoracic Society of Australia and New Zealand. Chapters in the current clinical guidelines
were drafted by a writing group and circulated to the whole expert group for comment
and revision. The document was then compiled into one text by the editor and circulated
to the group for review. Location: Journal article: https://doi.org/10.1111/resp.12764;
Executive Summary and Comprehensive version: https://www.thoracic.org.au/journal-
publishing/area?command=record&id=37. Description and key recommendations: The
2016 clinical practice guidelines were developed to update a 2008 consensus statement.
The aim was to optimise physiotherapy management of infants, children and adults with
cystic fibrosis in Australia and New Zealand by standardising physiotherapy care and
providing a reference tool to support training of physiotherapists and isolated
practitioners. Recommendations were drawn from a systematic review of published
literature, relevant conference proceedings and stakeholder review. Recommendations
were formulated based on the quality, quantity and level of the evidence according to
National Health and Medical Research Council guidelines; the consistency of the body of
evidence; the likely clinical impact; and generalisability and applicability to physiotherapy
practice in Australia and New Zealand. Thirty recommendations were made across eight
domains of physiotherapy practice for children and adults with cystic fibrosis, including:
airway clearance therapy (recommendations 1 to 5); inhalation therapy as an adjunct to
physiotherapy (recommendations 6 to 10); exercise assessment and training
(recommendations 11 to 15); musculoskeletal management (recommendations 16 to 18);
management of urinary incontinence (recommendations 19 to 21); managing the newly
diagnosed patient with cystic fibrosis (recommendations 22 to 23); delivery of non-
invasive ventilation (recommendations 24 to 28); and physiotherapy management before
andafter lungtransplantation(recommendations29to30).Thesearesummarisedattheend
of each chapter. Elements of clinical practice that were considered important but lacked
research evidence were highlighted as 47 ‘Practice Points’. These provided additional in-
formation on the aforementioned practice areas, as well as the areas of: physiotherapy for
pregnancy, labourandthepost-natalperiod(5points); thetransitionfrompaediatric toadult
care (1point); adherence tophysiotherapy(3points); infectioncontrolduringphysiotherapy
(7 points); and delivery of physiotherapy to inpatients and outpatients (3 points). The
guidelines conclude with 10 ‘Directions for future research’, which encourage research on:
effectiveness of individual respiratory techniques; combination of inhalation therapieswith
physiotherapy techniques; effectiveness of exercise and strength training; management of
musculoskeletal complications; andoptimal care for peoplewith chronic respiratory failure.
Provenance: Invited. Not peer reviewed.
Leanne M Johnston
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